TipRanks
Advertisement

RSP - ETF AI Analysis

Compare

Top Page

RSP

Invesco S&P 500 Equal Weight ETF (RSP)

Rating:70Outperform
Price Target:―
RSP, the Invesco S&P 500 Equal Weight ETF, earns a solid overall rating largely because many of its key holdings like NetApp, Synopsys, PTC, and Palo Alto Networks show strong financial performance, positive earnings outlooks, and strategic positioning in areas such as cloud, AI, and semiconductor design. However, some holdings such as Moderna and Pure Storage face challenges from high valuations, profitability or cash flow pressures, and mixed technical signals, which modestly weigh on the fund’s rating. The main risk factor is exposure to several stocks that appear overvalued or show potential bearish momentum, which could increase volatility if market conditions worsen.
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and over the past few months, showing healthy recent momentum.
Equal-Weight Diversification
Because it spreads investments more evenly across S&P 500 companies, the fund reduces reliance on just a few mega-cap stocks.
Broad Sector Coverage
Holdings are spread across many sectors, including technology, industrials, financials, and health care, which helps reduce the impact of weakness in any single industry.
Negative Factors
Mixed Top-Holding Performance
Some of the largest positions, such as PayPal, DoorDash, and Robinhood, have shown weak performance this year, which can drag on overall returns.
High U.S. Concentration
With almost all assets invested in U.S. companies, the fund offers little geographic diversification and is heavily tied to the U.S. economy.
Exposure to Volatile Growth Names
Several top holdings in areas like technology and newer platform businesses can be more volatile, making the fund more sensitive to swings in investor sentiment toward growth stocks.

RSP vs. SPDR S&P 500 ETF (SPY)

RSP Summary

RSP is the Invesco S&P 500 Equal Weight ETF, which follows the S&P 500 Equal Weighted Index. Instead of giving more weight to the biggest companies, it gives each of the 500 large U.S. companies the same importance. This means your money is spread more evenly across many sectors, including technology, financials, and health care. Well-known holdings include PayPal and Moderna. Someone might invest in RSP for broad diversification across large U.S. companies without being too dependent on mega-cap stocks. A key risk is that it can still rise and fall with the overall U.S. stock market.
How much will it cost me?The Invesco S&P 500 Equal Weight ETF (RSP) has an expense ratio of 0.20%, meaning you’ll pay $2 per year for every $1,000 invested. This is slightly higher than average for ETFs because it uses an equal-weight strategy, which requires more active management compared to traditional market-cap-weighted funds.
What would affect this ETF?The Invesco S&P 500 Equal Weight ETF (RSP) could benefit from a strong U.S. economy and growth in sectors like technology and industrials, which have significant weights in the fund. However, it may face challenges if interest rates rise, as this could pressure financial and consumer cyclical sectors, or if regulatory changes impact top holdings like Tesla and Intel. Its equal-weight strategy provides diversification but may underperform during periods when mega-cap stocks dominate market gains.

RSP Top 10 Holdings

RSP’s equal-weight approach means no single stock runs the show, but a few names still color the story. On the upside, fast-rising tech and cybersecurity players like CrowdStrike, Datadog, and Palo Alto Networks are helping power returns, while Moderna’s rebound adds extra fuel from the health care side. Illumina and Agilent are more steady contributors, keeping the pace rather than sprinting. Intuitive Surgical has been more mixed, occasionally losing steam and modestly tugging on performance. Overall, the fund is broadly diversified across U.S. large caps, with a noticeable tilt toward innovative tech and health care leaders.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Moderna0.35%$344.38M$94.42B738.18%
59
Neutral
PTC0.30%$295.91M$20.98B-4.87%
73
Outperform
Everpure0.27%$271.40M$44.45B35.01%
64
Neutral
Illumina0.26%$258.07M$40.46B175.03%
71
Outperform
Accenture0.25%$252.63M$137.64B-3.65%
79
Outperform
Mettler-Toledo0.25%$250.58M$32.84B20.23%
64
Neutral
Revvity0.25%$246.67M$17.26B63.39%
67
Neutral
Gartner0.24%$241.23M$13.09B-12.89%
67
Neutral
Agilent0.24%$239.50M$49.49B21.88%
73
Outperform
Intuitive Surgical0.24%$239.16M$151.15B-4.36%
78
Outperform

RSP Technical Analysis

Technical Analysis Sentiment
Positive
Last Price―
Price Trends
50DMA
215.34
Negative
100DMA
213.36
Positive
200DMA
205.35
Positive
Market Momentum
MACD
-0.15
Negative
RSI
54.16
Neutral
STOCH
76.28
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RSP, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 211.54, equal to the 50-day MA of 215.34, and equal to the 200-day MA of 205.35, indicating a neutral trend. The MACD of -0.15 indicates Negative momentum. The RSI at 54.16 is Neutral, neither overbought nor oversold. The STOCH value of 76.28 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RSP.

RSP Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
――$99.13B0.20%
70
Outperform
――$1.05T0.03%
74
Outperform
――$889.34B0.03%
74
Outperform
――$820.39B0.09%
74
Outperform
――$492.82B0.18%
73
Outperform
――$183.28B0.02%
74
Outperform
Performance Comparison
Ticker
Company Name
Price
Change
% Change
RSP
Invesco S&P 500 Equal Weight ETF
214.09
27.19
14.55%
VOO
Vanguard S&P 500 ETF
―
―
―
IVV
iShares Core S&P 500 ETF
―
―
―
SPY
SPDR S&P 500 ETF Trust
―
―
―
QQQ
Invesco QQQ Trust
―
―
―
SPYM
State Street SPDR Portfolio S&P 500 ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement